CW

Craig Wirth

Professional Summary



Professional Overview



Craig Wirth is an experienced finance and accounting professional with extensive expertise in the pharmaceutical and biotechnology industries. As the Associate Director of Medical Affairs Finance at Eisai US, he leverages his in-depth knowledge of financial planning, analysis, and reporting to drive strategic decision-making and support the company's medical affairs function.

Experience Summary



Current Role



As the Associate Director of Medical Affairs Finance at Eisai US, Craig is responsible for overseeing the financial management and reporting for the company's medical affairs department. In this role, he collaborates closely with cross-functional teams to align financial strategies with medical affairs initiatives, ensure efficient resource allocation, and provide valuable insights to support business objectives. Craig's strong analytical skills and data-driven approach have enabled him to identify cost-saving opportunities and optimize medical affairs budgets, contributing to the overall financial performance of the organization.

Career Progression



Craig's career in the pharmaceutical and biotechnology industries spans over 20 years, during which he has held various finance and accounting roles of increasing responsibility. Prior to his current position, he served as a Financial Planning & Analysis Consultant for the Medical Affairs team at Eisai US, where he played a key role in improving financial reporting processes and implementing effective budgeting strategies. Before that, Craig held positions as an Associate Director of Financial Planning and Analysis at PDS Biotechnology Corporation, Senior Manager of Financial Planning and Analysis at Molecular Templates, and Associate Director of Financial Planning and Analysis at Edge Therapeutics, Inc. and LEO Pharma Inc. US. Throughout his career, Craig has consistently demonstrated his ability to drive financial optimization, enhance business performance, and support strategic decision-making.

Academic Background



Craig holds a Bachelor of Science degree in Accounting from Rutgers University, where he graduated with honors. His strong academic foundation, coupled with his extensive industry experience, has allowed him to develop a well-rounded set of financial management skills and a deep understanding of the pharmaceutical and biotechnology sectors.

Areas of Expertise



  • Financial planning and analysis

  • Budgeting and forecasting

  • Cost control and optimization

  • Financial reporting and compliance

  • Cross-functional collaboration

  • Strategic decision-making

  • Medical affairs finance

  • Pharmaceutical and biotechnology industry knowledge


Professional Impact



During his tenure at Eisai US, Craig has successfully implemented streamlined financial reporting processes, enabling the medical affairs team to make more informed, data-driven decisions. Additionally, he has played a pivotal role in aligning medical affairs budgets with the company's overall strategic objectives, contributing to the efficient utilization of resources and the achievement of key performance targets. Craig's leadership and analytical skills have been instrumental in enhancing the financial health and operational efficiency of the medical affairs function within Eisai US.

Conclusion



With his extensive finance and accounting expertise, coupled with his deep understanding of the pharmaceutical and biotechnology industries, Craig Wirth is well-positioned to continue driving financial optimization and strategic decision-making in his role as the Associate Director of Medical Affairs Finance at Eisai US. His proven track record of success, coupled with his collaborative approach and data-driven insights, make him a valuable asset to the organization.